The Weekly Litigation News Digest is now live. Subscribe now

Use Of C-Type Natriuretic Peptide Variants To Treat Skeletal Dysplasia - EP3328416

The patent EP3328416 was granted to Biomarin Pharmaceutical on Mar 13, 2024. The application was originally filed on Aug 1, 2016 under application number EP16750584A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3328416

BIOMARIN PHARMACEUTICAL
Application Number
EP16750584A
Filing Date
Aug 1, 2016
Status
Granted And Under Opposition
Feb 9, 2024
Publication Date
Mar 13, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

GRAF VON STOSCH PATENTANWALTSGESELLSCHAFTDec 13, 2024LEPTHIENADMISSIBLE
SANDOZDec 12, 2024TER MEER STEINMEISTER & PARTNERADMISSIBLE
TEVA PHARMACEUTICALSDec 12, 2024KRAUS & LEDERER PARTGMBBADMISSIBLE

Patent Citations (18) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTEP0497368
INTERNATIONAL-SEARCH-REPORTUS2010297021
INTERNATIONAL-SEARCH-REPORTWO02074234
INTERNATIONAL-SEARCH-REPORTWO2009067639
OPPOSITIONCA2940835
OPPOSITIONCN102552177
OPPOSITIONEP2432489
OPPOSITIONUS2009163421
OPPOSITIONUS2010297021
OPPOSITIONUS2012316114
OPPOSITIONUS8198242
OPPOSITIONUS8598121
OPPOSITIONWO2004000347
OPPOSITIONWO2012088608
OPPOSITIONWO2013058833
OPPOSITIONWO2013059491
OPPOSITIONWO2016110577
OPPOSITIONWO2017020034

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents